Charles D. Pauza - 12 Oct 2025 Form 4 Insider Report for Traws Pharma, Inc. (TRAW)

Role
Chief Science Officer Virology
Signature
/s/ Charles David Pauza
Issuer symbol
TRAW
Transactions as of
12 Oct 2025
Net transactions value
$0
Form type
4
Filing time
15 Oct 2025, 20:08:46 UTC
Previous filing
03 Apr 2024
Next filing
16 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pauza Charles David Chief Science Officer Virology C/O TRAWS PHARMA, INC., 12 PENNS TRAIL, NEWTOWN /s/ Charles David Pauza 15 Oct 2025 0002018150

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRAW Stock Option (right to purchase) Award $0 +32,406 $0.000000 32,406 12 Oct 2025 Common Stock 32,406 $3.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 100% on the first anniversary of the grant date.